{
  "ticker": "TECH",
  "cik": "0000842023",
  "company_name": "BIO-TECHNE Corp",
  "filing_date": "2025-08-22",
  "item1_summary": " Bio-Techne and its subsidiaries develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide . Our Protein Sciences segment is a leading developer and manufacturer of high-quality biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy . Our Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays .\n Bio-Techne is committed to providing innovative, high-quality tools that allow our customers to make extraordinary discoveries and treat and diagnose diseases . Our common stock is listed on the NASDAQ under the symbol “TECH. ny in 1985 . We operate globally, with offices in many locations throughout North America, Europe and Asia .\n Our strategic pillars include: Grow & Leverage the Core. ing strategies that position us to serve as the standard for biological content in the research market . We expect to be able to convert our continued significant investment in our research and development activities to be first-to-market with quality products that are at the leading edge of life science researchers’ needs . We will continue to expand our sales staff and distribution channels globally .\n The Protein Sciences segment is the larger of our two segments, representing approximately 72% of our net sales in fiscal 2025 . The Reagent Solutions division consists of specialized proteins, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera and cell selection technologies . Key product brands include R&D Systems, Tocris Biosciences and Novus Biologicals .\n Analytical Solutions division includes manual and automated protein analysis instruments and immunoassays that are used in quantifying proteins in a variety of biological fluids . Key product brands include R&D Systems and ProteinSimple . Customers for this segment include researchers in academia and industry (chiefly pharmaceutical and biotech companies as well as contract research org .\n Analytical Solutions division is used chiefly by production and quality control departments at biotech and pharmaceutical companies . Diagnostics and Spatial Biology segment is focused primarily on the diagnostic and research markets . No single end-user customer accounted for more than 10% of Protein Sciences segment’s net sales during fiscal 2025, 2024, or 2023 .\n Lunaphore's COMET instrument automates ACD’s RNAscope assays and utilizies antibodies to enable simultaneous hyperplex detection of protein and RNA biomarkers on the same slide at single-cell resolution . The Molecular Diagnostics division markets and sells products and services under the Exosome Diagnostics and Asuragen brands .\n Customers for the Spatial Biology division include researchers in academia as well as investigators in pharmaceutical and biotech companies . We sell our products directly to those customers who are primarily located in North America, Europe, and China, and through distributors elsewhere . The majority of Diagnostic Reagents Division’s sales are through OEM agreements .\n The majority of our products are shipped within one day of receipt of the customers’ orders, other than our instruments and related cartridges . There was no significant backlog of orders for our products as of the date of this Annual Report on Form 10-K or as of a comparable date . No single supplier is material, although for some components that require particular specifications or regulatory or other qualifications there may be a single supplier ."
}